产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 |
CAS No. |
2014384-91-7 |
|---|---|
中文名称 |
(4S,10S,13S,16S,19S)-19-((S)-5-氨基-2-((S)-2-氨基-4-甲基戊酰胺基)-5-氧代戊酰胺基)-4-(((5S,8R,14S)-5-氨基甲酰基-15-(4-羟苯基)-8-(巯基甲基)-7,10,13-三氧代-2-硫杂-6,9,12-三氮杂十五烷-14-基)氨基甲酰基)-16-(2-羧乙基)-13-(羧甲基)-10-甲基-6,9,12,15,18-五氧代-5,8,11,14,17-五氮杂二十二烷二酸 |
英文名称 |
(4S,10S,13S,16S,19S)-19-((S)-5-amino-2-((S)-2-amino-4-methylpentanamido)-5-oxopentanamido)-4-(((5S,8R,14S)-5-carbamoyl-15-(4-hydroxyphenyl)-8-(mercaptomethyl)-7,10,13-trioxo-2-thia-6,9,12-triazapentadecan-14-yl)carbamoyl)-16-(2-carboxyethyl)-13-(carboxymethyl)-10-methyl-6,9,12,15,18-pentaoxo-5,8,11,14,17-pentaazadocosanedioic acid |
别名 |
Nangibotide;L-Methioninamide, L-leucyl-L-glutaminyl-L-α-glutamyl-L-α-glutamyl-L-α-aspartyl-L-alanylglycyl-L-α-glutamyl-L-tyrosylglycyl-L-cysteinyl- |
标准英文名 |
(4S,10S,13S,16S,19S)-19-((S)-5-amino-2-((S)-2-amino-4-methylpentanamido)-5-oxopentanamido)-4-(((5S,8R,14S)-5-carbamoyl-15-(4-hydroxyphenyl)-8-(mercaptomethyl)-7,10,13-trioxo-2-thia-6,9,12-triazapentadecan-14-yl)carbamoyl)-16-(2-carboxyethyl)-13-(carboxymethyl)-10-methyl-6,9,12,15,18-pentaoxo-5,8,11,14,17-pentaazadocosanedioic acid |
分子式 |
C54H82N14O22S2 |
分子量 |
1342.52 |
精确分子量 |
1342.52 |
SMILES |
OC(C=C1)=CC=C1C[C@@H](C(NCC(N[C@@H](CS)C(N[C@H](C(N)=O)CCSC)=O)=O)=O)NC([C@H](CCC(O)=O)NC(CNC([C@H](C)NC([C@H](CC(O)=O)NC([C@H](CCC(O)=O)NC([C@H](CCC(O)=O)NC([C@H](CCC(N)=O)NC([C@@H](N)CC(C)C)=O)=O)=O)=O)=O)=O)=O)=O |
标准SMILES |
CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(N)=O |
用途 |
Nangibotide is a TREM-1 receptor inhibitor that modulates innate immune responses; it reduces systemic and local inflammatory responses in rodent models of myocardial ischemia-reperfusion injury. |
InChIKey |
HZQYFECPKQJXFX-DAHMAOPXSA-N |
|
|
评论 |
|---|